Business Wire Feed
NeuroPace Announces FDA Approval of ECoG Assistant™, Advancing AI-Driven Epilepsy Care
-- First in a suite of planned NeuroPace AI tools designed to deliver deeper data insights, support clinical outcomes and further enhance efficiency of RNS therapy --MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--NeuroPace, Inc. (Nasdaq: NPCE), a medical more...
Seven-Year Analysis from Pfizer’s LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer
Patients had a 55% likelihood of remaining alive without disease progression at seven years, and median progression-free survival was not reached with LORBRENA Updated follow-up analysis solidifies LORBRENA as a preferred standard of care, building more...
Newron Pharmaceuticals to Participate in June Investor Conferences
MILAN & MORRISTOWN, N.J.--(BUSINESS WIRE)--$NWRN #Biotech--Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system (CNS), more...
FDA Grants Coredio Breakthrough Designation for AI Platform Bringing Advanced Heart Failure Assessment Beyond the Hospital
AI-powered platform uses consumer wearables to help clinicians monitor heart failure patients beyond the hospitalSANTA CLARA, Calif.--(BUSINESS WIRE)--Coredio, a digital health company developing the first software-as-a-medical-device (SaMD) platform dedicated to heart failure (HF) hemodynamic assessment, more...
The Governance Institute Announces Blue Ribbon Committee on Health System Governance
Nationally recognized board leaders and trustees, health system leaders, governance advisors, clinicians, academics, capital markets experts, and innovation leaders will convene this summer to help shape the next standard in the continuing development of healthcare more...
Tallahassee Memorial HealthCare and Inspirity Health Partners Launch Strategic Supply Chain Partnership
Collaboration builds on strong foundation to accelerate performance, deepen clinical integration and drive long-term valueROCHESTER, Minn.--(BUSINESS WIRE)--Inspirity Health Partners (IHP) has entered into a strategic, multi-year agreement with Tallahassee Memorial HealthCare (TMH) to advance and more...
athenahealth, Aetna CVS Health, and Catalyst Health Group Recognized for Advancing Real-Time Clinical Data Exchange
Co-innovation receives 2026 KLAS Points of Light and K2 Collaborative Peak Awards for connected value-based care workflowsBOSTON--(BUSINESS WIRE)--athenahealth today announced it received 2026 KLAS Points of Light and K2 Collaborative Peak awards alongside Aetna CVS more...
Medix Launches Executive Search Practice Focused on Revenue Cycle Leadership
OAK BROOK, Ill.--(BUSINESS WIRE)--Medix, a leading provider of workforce solutions to the healthcare industry, announced the launch of its Executive Search service offering dedicated to Revenue Cycle leadership. This new offering formalizes and expands Medix’s more...
eClinicalWorks AI-Powered EHR Strengthens Access to Care and Operational Efficiency at Rural Tennessee Clinic
Medical Specialty Clinic leverages eClinicalWorks unified solutions to support remote care and operations with AI-driven workflowsWESTBOROUGH, Mass.--(BUSINESS WIRE)--#AI--eClinicalWorks®, one of the largest ambulatory cloud EHR providers, announced that Medical Specialty Clinic, a Tennessee-based rural health more...
Beren Therapeutics Announces FDA Extension of Review Period for New Drug Application (NDA) for Adrabetadex for the Treatment of Infantile-Onset Niemann-Pick Disease, Type C
New PDUFA target action date of November 17, 2026 allows FDA additional time to complete its reviewTHOUSAND OAKS, Calif.--(BUSINESS WIRE)--Beren Therapeutics P.B.C.®, the parent company of Mandos LLC® and a leader in cholesterol trafficking biology more...
AI Meets Olfaction: SpotitEarly Unveils LUCID 2.0, Scaling Early Cancer Detection to Millions
Designed to process millions of tests per year, the Bio-AI platform builds on peer-reviewed research showing 94% sensitivity across four major cancers.ENGLEWOOD, N.J.--(BUSINESS WIRE)--SpotitEarly, an early cancer detection startup that uses AI and trained canines more...
WellSky® Unifies AI and the Patient Record in New Point of Care App for Home Health Clinicians
Included for all current WellSky Home Health clients, the new app is the first and only home health point-of-care solution that unifies AI-powered workflows, real-time clinical intelligence, and the full WellSky Home Health record onto more...
Cardio Diagnostics Holdings, Inc. to Showcase Precision Cardiovascular Solutions at Four National Benefits Conferences in June
These evidence-based solutions help employers, brokers, and unions tackle cardiovascular disease, a leading driver of medical claims and lost productivity.CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), an AI-powered precision cardiovascular medicine company, today announced that more...
Tempus Upgrades Its Smart Physician Platform, Hub, with Next-Generation Agentic AI Architecture to Streamline Clinical Workflows
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced a major technological upgrade to Tempus Hub, its AI-enabled smart physician platform. Tempus is making more...
Asahi Kasei Life Science Acquires License for Novel Antibody-Drug Conjugate Technology from The Noguchi Institute – A Major Milestone for More Efficient and Safer Cancer Treatments
TOKYO--(BUSINESS WIRE)--Asahi Kasei Life Science has acquired the license rights for a novel antibody-drug conjugate (ADC) technology from The Noguchi Institute. This modality enables precise control over the drug-to-antibody ratio and attachment site of single- more...
AngioDynamics to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today more...
Vistagen to Participate in Jefferies 2026 Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vistagen, a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines, today announced that the Company will participate more...
Harmony Biosciences to Participate in Upcoming Investor Conferences
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that Harmony's management team will participate in the following upcoming investor conferences. Goldman Sachs 47th Annual Global Healthcare Conference Fireside Chat: June 9, 2026, more...
Paysign, Inc. to Present at the Barrington Research Virtual Spring Investment Conference
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, today announced it will be presenting more...
Virchow Medical Strengthens Scientific Advisory Board with New Appointments
Board welcomes Mayo Clinic Laboratories CEO Dr. William Morice and Clinical Lab 2.0 Founder Khosrow Shotorbani; Second Annual In-Person Advisory Meeting in San Diego Drives Directions for Product DevelopmentSAN DIEGO--(BUSINESS WIRE)--#ClinicalLaboratories--Virchow Medical, Inc., a company more...
ClearNote Health Secures $52 Million in Series D Financing and Strengthens Leadership Team to Accelerate Growth in Early Cancer Detection
Proceeds will support continued commercial expansion, operational scale-up, clinical study execution, and product development Clinical oncology diagnostics veteran Kevin Keegan appointed president and chief operating officer SAN DIEGO--(BUSINESS WIRE)--#5hmC--ClearNote Health, a company dedicated to improving more...
Junevity to Present Breakthrough Research on siRNA Therapeutics at American Aging Association’s 2026 Annual Meeting
The company’s co-founder will deliver an oral presentation with the first ever data showing an siRNA therapeutic can restore global gene networks back to health in vivo The company to present applications of its RESET more...
Tempus Announces 37 Abstracts Accepted for Presentation at the 2026 American Society of Clinical Oncology Annual Meeting
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that 37 abstracts have been accepted for presentation at the 2026 American Society of Clinical more...
DePuy Synthes Announces Agreement to Acquire Miniature Radiofrequency Tracking Technology Across its Joint Reconstruction Portfolio
Agreement will bring first-to-market capabilities to eliminate line-of-sight dependency designed to improve simplicity and surgical flowRAYNHAM, Mass.--(BUSINESS WIRE)--DePuy Synthes, a global leader in orthopaedic technologies and solutions, today announced a definitive agreement to acquire selective more...
LIB Therapeutics Announces Results from Presentations on LEROCHOL® (lerodalcibep-liga) at the 2026 European Atherosclerosis Society Meeting in Athens, May 24-26, 2026
CINCINNATI--(BUSINESS WIRE)--LIB Therapeutics Inc. (LIB), a privately-held, biopharmaceutical company with a recently approved novel, monthly, small-dose, third-generation PCSK9 inhibitor, LEROCHOL® (lerodalcibep-liga), today announced results from two oral and two poster presentations at the European Atherosclerosis more...